Etiqueta: brazil

US giant J&J is one of the host of drugmakers with its foot down on efforts to produce a COVID-19 vaccine. The company, whose pharma division is led by Tatiana Marante in Argentina, is depending heavily on Latin America to test its candidate. Pharmabiz has learned that Argentina and...

Regulations on the use of treatments based on cannabidiol vary across the region. In Argentina, the use of medicinal oil must be requsted under "compassionate use". But a major Latin American player has become the representative of a US firm specialising in medicinal cannabis. The major Latin American multinational...

Pfizer's local general manager Nicolás Vaquer visited the presidential residence in Olivos on what was a holiday weekend in Argentina to tell President Alberto Fernández that Pfizer will carry out trials of its Covid-19 vaccine candidates in the country, generating a flurry of media hype. Pfizer's office in Argentina has...

English version Increasing numbers of executives are taking up positions remotely. One case is the new number one at US drugmaker Eli Lilly's Argentine office, which is now being led by the Brazilian Felipe Borges dos Reis from Brazil. Another executive has taken up his chair in Argentina remotely as the coronavirus...

English version Since Japan's Takeda acquired Shire in 2018, the drugmaker's course towards a specialist focus has been set. The sale of its portfolio of mature drugs has been predicted. Two local brands have changed hands for now as part of a deal with regional reach. Japan's Takeda has sold...

English version Germany's Schott, a specialist glass maker that produces glass for the pharmaceutical industry Pharmabiz to tour its manufacturing plant in Rio de Janeiro. The company told Pharmabiz that it would maintain its investments in the region where it operates three production sites, one in Rio where it makes raw materials; one that makes finished products in Sao...

English version The international recall of valsartan is directly impacting the cardio segment in Latin America. After the EMA made the first move and the FDA also stepped in, Pharmabiz analyzes the position of the Latin American regulators. The region's regulators have acted following the EMA's July 5 announcement of the revision of medicines based on valsartan manufactured with defective raw materials. Colombia,...

English version Brazil's Grupo Masipack, which manufactures machinery for the pharma sector, is in financial crisis. The president of the company blames the problems on the recession in Brazil. Brazil's Grupo Masipack, which manufactures machinery for the pharma sector, is suffering a financial crisis that is affecting delivery times for its products. As far as Pharmabiz could learn, the company is responding...

English version International consultation and auditing company KPMG is getting its data in a twist in Argentina, at least in the Pharma sector. International consultation and auditing company KPMG, one of the four giants on the global stage alongside Deloitte, PWC and Ernst & Young is getting its data in a twist in Argentina, at least in the Pharma...

English Version Brazilian firm Eurofarma has bought Sanofi’s plant in Lomas del Mirador, Argentina. The decision comes after a long process of due diligence in which the company, overseen by Mauricio Billi, looked closely at its figures. Brazilian firm Eurofarma has bought Sanofi’s plant in Argentina. The decision comes after a long process of due diligence in which the company, overseen...

The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event had a special flavour this year because IMS is celebrating 40 years in Argentina. English version The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event...